The global drug of abuse (DOA) testing market was valued at USD 7.2 billion in 2023. The driving factor for the growth of the market includes the advancement in technology for the development and production of DOA products with high specificity and sensitivity against complex new designer drugs. The reduction in testing time with newly developed products also drives the growth of the market. Additionally, government initiatives to increase awareness towards drug abuse, and also the global rise in production and trade of drugs are expected to render growth of the market.
Among different products, the rapid test kits held the largest share of 26.8% in the DOA testing market in 2017, globally. This is primarily due to the easy availability of reliable on the spot testing of drugs through rapid test kits. Other products categories include immunoassay analyzers, chromatography instruments, breath analyzers, and assay kits & reagents.
Based on the sample type, the DOA testing market is segmented into urine, saliva, hair, and others. The most common form of the sample used for the drug of abuse testing is urine, due to the presence of parent drug or metabolites that can help detect the presence of many illicit drugs. This led to the high demand for urine as a sample type for DOA testing with a contribution of more than 50% in the market in 2017.
Browse Market Insight and In-depth ToC on “Global Drug of Abuse (DOA) Testing Market – Analysis and Forecast (2025-2030)
The hospitals are the largest end user to the DOA testing market, due to the availability of products and clinicians in hospitals that conduct research as well as new drug testing on a large scale. Some of the other end users of drug of abuse testing solutions include diagnostic laboratories, on-the-spot testing, forensic laboratories, and others.
Global Drug of Abuse (DOA) Testing Market Segmentation and Key Players
Immunoassay Analyzers, Chromatography Instruments, Breath Analyzers, Rapid Test Kits, Assay Kits & Reagents
Urine, Saliva, Hair, Others
Hospitals, Diagnostic laboratories, On-the-spot Testing, Forensic Laboratories, Others
Danaher Corporation, Siemens AG, Merck KGaA, Drägerwerk AG & Co. KGaA, bioMérieux S.A., Waters Corporation, F. Hoffmann-La Roche AG, Quest Diagnostics Inc., Laboratory Corporation of America Holdings, Abbott Laboratories, ThermoFisher Scientific Inc., Express Diagnostics Int'l, Inc., Randox Laboratories Ltd., Psychemedics Corporation, and Bio-Rad Laboratories, Inc.
Asia-Pacific DOA testing industry is expected to witness significant growth at a high CAGR of 10.4% during the forecast period. The growth is driven by rising production, as well as the consumption of illicit drugs. In addition, the rise in organizational compliance for testing of drug of abuse at the workplace will also drive the growth of the regional market.
The increase in trade of these drugs has also led to the fast growth of the region. According to the UNODC World Drug Report of 2016, the total value of illicit opiates trafficked on the Balkan route to Europe is estimated to amount to an average of USD 28 billion per annum. The report also states that on a global level, South-West Asia is marked by high levels of opiate use, with 2-2.5 million people in Afghanistan alone are estimated to use drugs.
The key players of the DOA testing industry are Siemens AG, Danaher Corporation, Merck KGaA, Laboratory Corporation of America Holdings, Express Diagnostics Int'l, Inc., Hologic Inc., Drägerwerk AG & Co. KGaA, bioMérieux S.A., Quest Diagnostics Inc., Waters Corporation, Abbott Laboratories, Randox Laboratories Ltd., Psychemedics Corporation, Bio-Rad Laboratories, Inc., Thermo Fisher Scientific Inc., F. Hoffmann-La Roche AG, and Sonic Healthcare Ltd.
The DOA testing players are undergoing collaborations and acquisition of other players to gain larger market share. In January 2017, Sonic Healthcare Limited signed a binding agreement for the acquisition of Medical Laboratory Bremen, with operations in two medical laboratories in the North West of Germany, focus on specialty testing. The company’s acquisition was closed with a purchase price of €63 million, with a strategic commitment to grow in laboratory medicine.
Global DOA Testing Coverage
Product Insight and Forecast 2025-2030
Sample Type Insight and Forecast 2025-2030
End User Insight and Forecast 2025-2030
DOA Testing Market by Region
Rest of the World (RoW)
About VynZ Research
VynZ Research is a global market intelligence company providing research reports, industry intelligence and business advisory services to companies and institutions across the globe. We have a recognized trajectory record and our research database is used by many renowned companies and institutions in the world to strategize and revolutionize business opportunities.
VynZ Research helps clients to make informed decisions in their businesses! We build market intelligence reports with fact-based research that includes comprehensive analysis and quantification of market drivers, dynamics, opportunities, restraints, threats, market shares and emerging trends arising across a wide range of industries. VynZ Research team is fully committed to providing the highest level of market intelligence reports that help its client in gaining competitive advantage and obtaining requisite strategic insights. We provide syndicated research reports or custom research requirements based on rigorous market studies and consulting services to our esteemed clients across the globe.
165 Broadway, 23rd Floor,
New York City, New York - 10006
United States of America